Radiochemical synthesis and preliminary in vivo evaluation of new radioactive platinum complexes with carnosine

Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
Michal Maurin, Piotr Garnuszek

Abstract

Application of cross-linking agents such as SATA and 2-iminothiolane (2-IT) for radiochemical synthesis of new radioactive Pt(II) and Pt(IV) complexes with carnosine was investigated. The mixed-ligand Pt(II)([(125)I]Hist)(Carnosine) complex has been synthesized in a multi-step reaction. First, carnosine was modified by the attachment of SATA. After chromatographic purification, the conjugate was unprotected to form a reactive sulfhydryl functional group, and then the modified carnosine was substituted to PtCl(2)[(125)I]Hist complex. The Pt(II)(IT-[(125)I]Carnosine) and Pt(IV)(IT-[(131)I]Carnosine) complexes were synthesized in a three-step reaction. First, carnosine was labeled with iodine radionuclide ((125)I or (131)I), followed by conjugation with 2-IT. The modified IT-[*I]Carnosine was complexed with tetrachloroplatinate or hexachloroplatinate. Comparative biodistribution studies were performed in normal Wistar rats and in Lewis rats with implanted (s.c.) rat pancreatic tumor cells (AR42J). The HPLC analysis showed a relatively fast formation of the new mixed-ligand Pt([(125)I]Hist)(Carnosine) complex (yield ca. 50% after 20h). Reaction of K(2)PtCl(4) with [(125)I]Carnosine modified by 2-IT proceeded rapidly and with a high...Continue Reading

References

Jan 1, 1990·Critical Reviews in Oncology/hematology·C N Coleman, A T Turrisi
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R MastrangeloL Troncone
Jan 9, 1998·International Journal of Radiation Oncology, Biology, Physics·R SauerP Martus
Jun 16, 2000·Age and Ageing·S E Gariballa, A J Sinclair
Dec 29, 2000·Cancer Chemotherapy and Pharmacology·G P AmorinoH Choy
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·J ArebergS Mattsson
Dec 26, 2001·Chemical Reviews·H Ali, J E van Lier
Aug 19, 2003·European Journal of Pharmacology·Toshihide FujiiYasuo Matsumura
Feb 28, 2004·Journal of Inorganic Biochemistry·Piotr GarnuszekJanina Witowska-Jarosz
Jan 16, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Salvatore CuzzocreaCarlo Vancheri
May 1, 2008·Environmental Toxicology and Pharmacology·Amr A FouadWafaey Gomaa

❮ Previous
Next ❯

Citations

Mar 24, 2020·Chemical Research in Toxicology·Klaudia ChmielewskaMaja Przybyłowska

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.